Hepatotoxicity associated with the ingestion of Centella asiatica;Hepatotoxicidad asociada al consumo de Centella asiática

Revista Espanola de Enfermedades Digestivas

Volumn 97, Issue 2, 2005, Pages 115-124

  Jorge, Oliver A ^a,b,c   Jorge, A D ^a,c  

^a HOSPITAL ESPAÑOL   (Argentina)

^b Hospital Español de Mendoza ^*  (Argentina)

^c HOSPITAL ESPAÑOL DE MENDOZA   (Argentina)

Author keywords

Apoptosis; Centella asiatica; Hepatotoxicity; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASIATICOSIDE; BILIRUBIN; CENTELLA ASIATICA EXTRACT; MADECASSOSIDE; PREDNISONE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BILIRUBIN BLOOD LEVEL; CASE REPORT; CELL MEMBRANE; CENTELLA ASIATICA; CLINICAL FEATURE; FEMALE; GRANULOMATOUS HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; INFLAMMATION; JAUNDICE; LIVER CIRRHOSIS; LIVER NECROSIS; LIVER TOXICITY; WEIGHT REDUCTION;

EID: 17144423211     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082005000200006     Document Type: Article

References (63)

1. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997; 26 (Supl. 1): 47-51.
2. Koff R. Herbal hepatotoxicity: revisiting a dangerous alternative. JAMA 1995; 273: 502.
3. Seef L, Lindsay K, Bacon B, et al. Complementary and alternative medicine in chronic liver disease. Hepatology 2001; 34: 595-603.
4. Kessler R, Davis R, Foster D, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001; 135: 262-8.
5. Eisenberg D, Kessler R, Van Rampay M, et al. Perceptions about complementary therapies relatives to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001; 135: 344-51.
6. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002; 22: 195-206.
7. Grahan-Brown R. Toxicity of Chinese herbal remedies. Lancet 1992; 340: 673-4.
8. Shimizu J. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinonona. Gastroenterol Hepatol 2000; 15 (Supl.): D84-90.
9. Melchart D, Linde K, Weidenhammer W, et al. Liver enzyme elevation in patients treated with traditional Chinese medicine. JAMA 1999; 282: 28-9.
10. Borum M. Fulminant exacerbation of autoimmune hepatitis after the use of Ma-Huang. Am J Gastroenterol 2001; 96: 1654-5.
11. Nadir A, Agrawal S, King D, et al. Acute hepatitis associated with the use of a Chinese herbal product, Ma-Huang. Am J Gastroenterol 1996; 91: 1436-8.
12. Picciotta A, Campo N, Brizzolara R, et al. Chronic hepatitis induced by Jin Bu Huan. J Hepatol 1998; 28: 165-7.
13. Woolf G, Petronic L, Rojter S, et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994; 121: 729-35.
14. Itoh S, Marutani K, Nishijima T, et al. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995; 40: 1845-8.
15. Brown D. Encyclopedia of herbs and their uses. Dorley Kindersley Pub. 1995.
16. st ed. Medical Economics Co, 1999. p. 729.
17. Herbert D, Paramasivan C, Prabhakar R, et al. In vitro experiments with Centella asiatica: investigation to elucidate the effect of an indigenously prepared powder of this plant on the acid-fastness and viability of M tuberculosis. Indian J Lepr 1994; 66: 65-8.
18. Baily E. Treatment of leprosy. Nature 1945; 155: 601.
19. Morganti P, Fionda A, Elia V, et al. Extraction and analysis of cosmetic active ingredients from an anti-cellulitis transdermal delivery system by high-performance liquid chromatography. J Chromatogr Sci 1999; 37: 51-5.
20. Duke J. Handbook of Medicinal Herbs. Boca Raton, Fl CRC Press, 1985.
21. Brinkhaus B, Lindner M, Schuppan D, et al. Chemical, pharmacological and clinical profile of the East Asian medical plant centella asiatica. Phytomedicine 2000; 7: 427-48.
22. Lee M, Kim S, Sung S, et al. Asiatic acid derivatives protect cultured cortical neurons from glutamate-induced excitotoxicity. Res Commun Mol Pathol Pharmacol 2000; 108: 75-86.
23. Mook-Jung I, Shin JE. Protective effects of asiaticoside derivates against beta-amyloid neurotoxicity. J Neurosci Res 1999; 58: 417-25.
24. Incandela L, Cesarone M, Cacchio M, et al. Total triterpenic fraction of centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. Angiology 2001; 52 (Supl. 2): s9-13.
25. Cesarone MR, Incandela L, DeSanctis MT, et al. Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of centella asiatica: a clinical prospective randomized trial with a microcirculatory model. Angiology 2001; 52 (Supl. 2): s49-54.
26. Widgerow A, Chait L, Stals R, et al. New innovations in scar management. Aesthetic Plast Surg 2000; 24: 227-34.
27. Young G, Jewell D. Creams for preventing stretch mark in pregnancy. Cochrane Database Syst Rev 2000; 2: CD000066.
28. Sampson J, Ramon A, Karlsen G, et al. In vitro keratinocyte anti proliferant effect ïCentella asiatica extract and triterpenoid saponins. Phytomedicine 2001; 8: 230-5.
29. Gonzalo Garijo M, Revenga Arnanz F, Bobadilla Gonzalez P. Allergic contact dermatitis due to Centella asiatica: a new case. Allergon Inmunopathol 1996; 24: 132-4.
30. Bilbao J, Aguirre A, Zabala R, et al. Allergic contact dermatitis from butosyethyl nicotinic acid and Centella asiatica extract. Contact Dermatitis 1995; 33: 435-6.
31. Eun HC, Lee AY. Contact dermatitis due to madecassol. Contact dermatitis 1985; 13: 310-3.
32. Duta T, Basu UP. Crude extract of centella asiatica and products derived from its glycosides as oral antifertility agents. Ind J Exp Biol 1968; 6: 181.
33. Desmet PAGM. Herbal remedies. N Engl J Med 2002; 347: 2046-56.
34. Kaplowitz N. Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death. Gastroenterology 1997; 113: 1408-12.
35. Watson WH, Dahm LJ, Jones DP. Mechanisms of chemically induced liver disease. En Zakim D, Boyer TD. Hepatology. A text book of Liver Disease. Philadelphia: Saunders, 2003. p. 739-53.
36. Terpenos. Enciclopedia Visor Edición Latinoamericana. Buenos Aires: Visor Easa, 1999.
37. Combinaciones alicíclicas. En: Química General. Enciclopedia Labor. Barcelona: Ed. Labor S.A., 1963; Tomo II: 517-22.
38. Sesquiterpene. Polyterpene. Sterine. Vitamine. En: Karrer P. Lehrbuch der organischen CEIME. Stuttgart: Thieme Verlag, 1963. p. 726-74.
39. Mulet L. Estudio etnobotánico de la provincia de Castellón. Castellón: Diputación Provincial, 1991.
40. Saponinas y saponósidos. En: Mulet L. Flora tóxica de la Comunidad Valenciana. Castellón. Diputación Provincial, 1997.
41. Fau D, Lekehal M, Parrel G, et al. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 1997; 113: 1334-46.
42. Lekehal M, Pessayre D, Lereau JM, et al. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytocrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996; 24: 212-8.
43. Haouzi D, Lekehal M, Moreau A, et al. Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology 2000; 32:303-11.
44. Uc A, Bishop WP, Sanders KD. Camphor hepatotoxicity. South Med J 2000; 93: 596-8.
45. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002; 22: 145-55.
46. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993; 46: 1331-6.
47. Larrey D. Drug-induced liver diseases. J Hepatol 2000; 32: 77-88.
48. Bissell DM, Gores GJ, Laskin DL, et al. Drug-induced liver injury: mechanism and test systems. Hepatology 2001; 33: 1009-13.
49. Kaplowitz N. Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology 2001; 33: 308-9.
50. DeBerardinis V, Moulis C, Maurice M, et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000; 58: 542-51.
51. Kamiyama T, Nauchi T, Kojima S, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997; 92: 703-4.
52. Spielberg SP. In vitro assessment of pharmacogenetic susceptibility to toxic drug abolites in humans. Federation Proc 1984; 43: 2308-13.
53. Stickel F, Baumüller HM, Seitz K, et al. Hepatitis induced by kava. J Hepatol 2003; 39: 62-7.
54. Mattei A, Rucay P, Samuel D, et al. Liver transplantation for acute liver failure after herbal medicine (teucrium polium) administration. J Hepatol 1995; 22: 597.
55. Yoshida EM, McLean CA, Cheng ES, et al. Chinese herbal medicine, fulminant hepatitis and liver transplantation. Am J Gastroenterol 1996; 91: 2647-8.
56. Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: Measurement of toxic metabolites in two cases and review of the literature. Ann Intern Med 1996; 124: 726-34.
57. Poupon RE, Bonnand AM, Chretien Y, et al. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Hepatology 1999; 29: 1668-71.
58. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid: "mechanisms of action and clinical use in hepatobiliary disorders". J Hepatol 2001; 35: 134-46.
59. Rodrigues CMP, Fan G, Ma X, et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998; 101: 2790-9.
60. Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Sem Liver DIS 2002; 22: 137-44.
61. Guma C, Thome N, Viola L, et al. Tratamiento con ácido ursodeoxicólico en la hepatitis por drogas: Resultados de un estudio piloto y controlado. Resúmenes del XII Congreso Argentino de Hepatología: Buenos Aires, 2003 Jul 1-4.
62. Farrell GC. Drug-induced liver disease. Edinburgh, Churchill Livingstone, 1994. p. 513-8.
63. Moore DH, Benson GD. Prolonged halothane hepatitis: prompt resolution of severe lesion with corticosteroid therapy. Dig Dis Sci 1986; 31: 1269-7.